The key determinant is plasma-membrane integrity. Cells with intact membranes exclude the dye and contribute little or no nuclear fluorescence, whereas membrane disruption permits entry and access to DNA. Signal intensity therefore reflects the presence of membrane-compromised cells in the sample, allowing researchers to distinguish damaged or dead populations from viable cells.
DNA binding concentrates the fluorescent stain within the cell nucleus, creating a measurable signal rather than relying only on dye distribution throughout the sample. This localization helps microscopy and flow cytometry identify individual cells with disrupted membranes. The resulting fluorescence provides a practical readout for comparing the relative extent of cell damage across biological samples.
Samples can be interpreted by separating cells with detectable nuclear fluorescence from those lacking a signal. Fluorescent cells indicate membrane damage sufficient for dye entry, while nonfluorescent cells are consistent with intact membranes. Comparing these populations supports quantitative assessment of viability and helps reveal changes in cell injury between experimental conditions.
In a microscopy assay, the dye is applied to the biological sample and fluorescence is examined at the cellular level. Researchers identify nuclei that become fluorescent and determine where membrane-compromised cells occur. This approach can show the distribution of cell injury while also supporting comparisons among samples exposed to different infection or treatment conditions.
Flow cytometry measures fluorescence from individual cells as they pass through the instrument, enabling researchers to quantify fluorescent and nonfluorescent populations. With an impermeable DNA dye, this separates cells showing membrane disruption from those retaining membrane integrity. The resulting population measurements are useful for comparing infection severity, immune-mediated injury, or treatment responses.
The assay is particularly informative when researchers need to measure host-cell death or pathogen-associated cytotoxicity. In infection studies, fluorescence-based population comparisons can indicate differences in cellular injury between conditions. In immunology, the same readout supports evaluation of immune-mediated damage and helps assess whether treatments alter the extent of host-cell loss.